Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature

American Journal of Health-System Pharmacy

Volumn 67, Issue 11, 2010, Pages 895-900

  Charneski, Lisa ^a   Congdon, Heather Brennan ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Anemia; Anticoagulants; Aspirin; Dipyridamole; Heparin; Platelet aggregation inhibitors; Protocols; Thrombosis; Ticlopidine; Vascular diseases

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ACENOCOUMAROL; ACETYLSALICYLIC ACID; D DIMER; DIPYRIDAMOLE; HEMOGLOBIN; HEPARIN; PROTHROMBIN; THROMBIN; TICLOPIDINE; TINZAPARIN; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ABDOMINAL DISCOMFORT; ANTICOAGULANT THERAPY; BLEEDING; BLOOD VESSEL OCCLUSION; DRUG EFFECT; DRUG EFFICACY; EOSINOPHILIA; GINGIVA BLEEDING; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; LENGTH OF STAY; NAUSEA; OXYGEN SATURATION; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SICKLE CELL CRISIS; SKIN PRURITUS; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE LIFESPAN; THROMBOSIS; CLINICAL TRIAL; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; SICKLE CELL ANEMIA; STANDARD; THROMBOCYTE; VASCULAR DISEASE;

ANEMIA, SICKLE CELL; ANTICOAGULANTS; BLOOD PLATELETS; CLINICAL TRIALS AS TOPIC; HUMANS; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; VASCULAR DISEASES;

EID: 77955913481     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp090229     Document Type: Review

References (17)

1. Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999; 340:1021-30. (Pubitemid 29157635)
2. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program. 2007; 2007:91-6.
3. Lanzkron S, Strouse JJ, Wilson R et al. Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med. 2008; 148:939-55. (Pubitemid 351860826)
4. Ansell J, Hirsh J, Hylek E et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edition. Chest. 2008; 133(suppl):160S-198S.
5. Hebbel RP. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. N Engl J Med. 2000; 342:1910-2. (Pubitemid 30419059)
6. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med. 2003; 115:721-8. (Pubitemid 38032666)
7. Alkjaersig N, Fletcher A, Joist H et al. Hemostatic alterations accompany sickle cell pain crises. J Lab Clin Med. 1976; 88:440-9.
8. Osamo NO, Photiades DP, Famodu AA. Therapeutic effect of aspirin in sickle cell anaemia. Acta Haematol. 1981; 66:102-7. (Pubitemid 11041813)
9. Greenberg J, Halus J. Trial of low doses of aspirin as prophylaxis in sickle cell disease. J Pediatr. 1983; 102:781-4. (Pubitemid 13089418)
10. Zago MA, Costa FF, Ismael SJ et al. Treatment of sickle cell diseases with aspirin. Acta Haematol. 1984; 72:61-4. (Pubitemid 14028625)
11. Chaplin H, Alkjaersig N, Fletcher AP et al. Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises. Thromb Haemost. 1980; 43:218-21. (Pubitemid 10044802)
12. Semple MJ, Al-Hasani SF, Kioy P et al. A double-blind trial of ticlopidine in sickle cell disease. Thromb Haemost. 1984; 51:303-6. (Pubitemid 14097879)
13. Chaplin H, Monroe MC, Malecek AC et al. Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises. East Afr Med J. 1989; 66:574-84.
14. Qari MH, Aljaouni SK, Alardawi MS et al. Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. Thromb Haemost. 2007; 98:392-6. (Pubitemid 47250243)
15. Salvaggio JE, Arnold CA, Banov CH. Long-term anticoagulation in sickle-cell disease: a clinical study. N Engl J Med. 1963; 269:182-6.
16. Schnog JB, Kater AP, Mac Gillavry MR. Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study. Am J Hematol. 2001; 68:179-83. (Pubitemid 32983206)
17. Ahmed S, Siddiqui AK, Iqbal U et al. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report. Eur J Haematol. 2004; 72:213-6. (Pubitemid 38250799)